Skip to main content

UNC Receives $17 Million to Develop AI-Enabled Obstetric Ultrasound

August 22, 2022

UNC-Chapel Hill has received a $17 million grant from the Bill & Melinda Gates Foundation to continue groundbreaking work in artificial intelligence (AI)-enabled obstetric ultrasound. CHAPEL HILL, NC – The new award will support an interdisciplinary team from the UNC School of Medicine and Gillings School of Global Public Health, with collaborators in Zambia, Kenya, … Read more

Victoria Shelus Studies Antimalarial Drug Use and Practice at Drug Shops in Uganda

August 13, 2022

In the remote villages of Bugoye sub-county at the foot of Uganda’s Rwenzori Mountains a rolling landscape stretches across lush river valleys and steep hillsides. It’s the kind of terrain that might make for a beautiful and strenuous weekend hike for visitors but not necessarily for the people who live there. Residents of this region … Read more

I AM IGHID: Joelle Howard

August 12, 2022

Regulatory Affairs (RA) plays a critical role throughout the grant lifecycle, ensuring protocol integrity in the development of drugs and vaccines on the path to human use. Joelle Howard, who goes by Jo, joined IGHID last June. She is one of three regulatory document specialists who work across departments, schools, and countries to maintain accurate … Read more

IGHID Investigators Discuss Projects As New Academic Year Begins

August 12, 2022

Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations. Their multi-disciplinary findings will be … Read more

Addressing Racism’s Role in the US HIV Epidemic: Qualitative Findings from Three “Ending the HIV Epidemic” Prevention Projects

August 8, 2022

Researchers from the Institute for Global Health and Infectious Diseases, the Gillings School of Global Public Health, and Center for Health Equity Research reviewed qualitative data from three “Ending the HIV Epidemic” (EHE) projects, published in the July issue of Journal of Acquired Immune Deficiency Syndrome (JAIDS). In the article, Kate Muessig, PhD, associate professor … Read more

Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis

August 8, 2022

Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in more than a decade that … Read more

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

August 1, 2022

Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). “HIV infection … Read more

CDC renews five-year funding for vector-borne disease threats

July 25, 2022

The Center for Disease Control and Prevention (CDC) has announced the five-year funding renewal of the Southeastern Center for Vector-Borne Diseases (SECVBD), an interdisciplinary team of researchers that includes UNC’s Ross Boyce, MD, MSc, a member of the UNC Institute for Global Health & Infectious Diseases and assistant professor in infectious diseases and epidemiology, and … Read more

Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens

June 24, 2022

Recently published in eBioMedicine, this study represents the work of the late Professor Steve Meshnick who served as mentor to Andreea Waltmann, a postdoctoral scholar with the Institute for Global Health & Infectious Diseases. Dr. Meshnick died August 5, 2020.  Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination … Read more

NIAID recognizes HPTN’s groundbreaking work in covid prevention tools

June 9, 2022

The 2022 HPTN Annual Meeting took place June 5-8 in Washington, D.C., bringing hundreds of worldwide researchers, collaborators, community representatives, and government health officials together to share updates and accomplishments and re-engage with each other as a community. HPTN Principal Investigators Myron Cohen, MD, director of the UNC Institute for Global Health & Infectious Diseases … Read more

Baric led center receives $65 million grant

June 8, 2022

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery (AViDD) Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19. The center builds upon and is … Read more

Effect of intimate partner violence on oral PrEP adherence among adolescent girls and young women

June 7, 2022

Intimate partner violence events may either impede or motivate PrEP adherence among African adolescent girls and young women, with age appearing to be an important consideration for IPV-related adherence interventions, according to IGHID researchers Lisa Hightow-Weidman, MD, MPH, professor of infectious diseases and principal investigator for the UNC Behavioral and Technology Lab, and Audrey Pettifor, … Read more

Researchers evaluate diagnostic testing landscape for tick-borne disease in the Southeast

May 17, 2022

Tick-borne diseases (TBD) including Spotted Fever Group Rickettsiosis (SFGR), ehrlichiosis, and increasingly Lyme disease, represent a substantial public health concern throughout much of the Southeastern United States. North Carolina experiences some of the highest rates of SFGR and ehrlichiosis in the United States, often accounting for more than of 10% and 5% of cases reported to the … Read more

UNC Global Clinical Trials Unit Launches Largest COVID-19 Observational Study of its Kind in North Carolina

May 15, 2022

UNC Has Launched the Largest COVID-19 Observational Study of its Kind in North Carolina The VISION study led by the UNC Institute for Global Health & Infectious Diseases is enrolling 7,500 COVID-positive individuals in North Carolina to answer critical questions about their health through online surveys. Approximately 750 participants will also be seen in person … Read more

NIH Renews the UJMT Fogarty Global Health Training Partnership

May 6, 2022

The UJMT Fogarty Global Health Fellows Consortium (UJMT)–a partnership between UNC-Chapel Hill, Johns Hopkins University, Morehouse School of Medicine and Tulane University–has been renewed for the coming five years. It is one of seven groups to be funded under the new Launching Future Leaders in Global Health (LAUNCH) training initiative, supported by the Fogarty International … Read more